糖尿病管理的不同视角：控制病毒性肝病
A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases.
作者信息
Zhao Yingying, Xing Huichun
机构信息
Department of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, China.
出版信息
J Diabetes Res. 2017;2017:5625371. doi: 10.1155/2017/5625371. Epub 2017 Mar 2.
Abstract
Knowing how to prevent and treat diabetes mellitus (DM) earlier is essential to improving outcomes. Through participating in synthesis and catabolism of glycogen, the liver helps to regulate glucose homeostasis. Viral related liver diseases are associated with glycometabolism disorders, which means effective management of viral liver diseases may be a therapeutic strategy for DM. The present article reviews the correlation between DM and liver diseases to give an update of the management of DM rooted by viral liver diseases.
摘要
尽早了解如何预防和治疗糖尿病对于改善预后至关重要。肝脏通过参与糖原的合成与分解代谢，有助于调节葡萄糖稳态。病毒性肝病与糖代谢紊乱相关，这意味着有效管理病毒性肝病可能是治疗糖尿病的一种策略。本文综述了糖尿病与肝病之间的相关性，以更新基于病毒性肝病的糖尿病管理方法。
相似文献
1
A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases.糖尿病管理的不同视角：控制病毒性肝病
J Diabetes Res. 2017;2017:5625371. doi: 10.1155/2017/5625371. Epub 2017 Mar 2.
2
Effects of ginsenoside Rg1 on glucose metabolism and liver injury in streptozotocin-induced type 2 diabetic rats.人参皂苷Rg1对链脲佐菌素诱导的2型糖尿病大鼠糖代谢及肝损伤的影响
Genet Mol Res. 2017 Mar 30;16(1):gmr-16-01-gmr.16019463. doi: 10.4238/gmr16019463.
3
Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents.2型糖尿病中的肝功能障碍与胰岛素抵抗：胰岛素增敏剂的关键作用靶点
Diabetes Obes Metab. 2008 Sep;10(9):699-718. doi: 10.1111/j.1463-1326.2007.00761.x. Epub 2007 Sep 6.
4
Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice.银杏叶提取物改善链脲佐菌素诱导的小鼠1型糖尿病和高脂饮食诱导的小鼠2型糖尿病。
Int J Med Sci. 2015 Nov 23;12(12):987-94. doi: 10.7150/ijms.13339. eCollection 2015.
5
[Therapeutic effects of gegen qinlian decoction and its mechanism of action on type 2 diabetic rats].葛根芩连汤对2型糖尿病大鼠的治疗作用及其作用机制
Yao Xue Xue Bao. 2013 Sep;48(9):1415-21.
6
Past and current perspective on new therapeutic targets for Type-II diabetes.2型糖尿病新治疗靶点的过去与当前观点
Drug Des Devel Ther. 2017 May 22;11:1567-1583. doi: 10.2147/DDDT.S133453. eCollection 2017.
7
[Role of the liver in the regulation of glucose metabolism in diabetes and chronic liver disease].[肝脏在糖尿病和慢性肝病中葡萄糖代谢调节中的作用]
Ann Ital Med Int. 1997 Apr-Jun;12(2):84-91.
8
Testosterone supplementation improves glucose homeostasis despite increasing hepatic insulin resistance in male mouse model of type 2 diabetes mellitus.在2型糖尿病雄性小鼠模型中，睾酮补充剂尽管会增加肝脏胰岛素抵抗，但仍能改善葡萄糖稳态。
Nutr Diabetes. 2016 Dec 12;6(12):e236. doi: 10.1038/nutd.2016.45.
9
Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.口服葡萄糖耐量试验前后的皮下微透析：一种测定糖尿病患者皮下脂肪组织胰岛素抵抗的方法。
Diabetes Obes Metab. 2005 Sep;7(5):525-35. doi: 10.1111/j.1463-1326.2004.00424.x.
10
[Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].2型糖尿病患者发生非酒精性脂肪肝的代谢危险因素分析
Zhonghua Gan Zang Bing Za Zhi. 2014 Aug;22(8):631-5. doi: 10.3760/cma.j.issn.1007-3418.2014.08.016.
引用本文的文献
1
A Prospective Study to Identify the Prevalence of Impaired Glucose Tolerance in Patients With Liver Cirrhosis Using Oral Glucose Tolerance Test.一项使用口服葡萄糖耐量试验确定肝硬化患者糖耐量受损患病率的前瞻性研究。
Cureus. 2023 Apr 28;15(4):e38269. doi: 10.7759/cureus.38269. eCollection 2023 Apr.
2
Gut Microbiome Alterations and Hepatic Metabolic Flexibility in the Gansu Zokor, : Adaptation to Hypoxic Niches.甘肃鼢鼠的肠道微生物群改变与肝脏代谢灵活性：对低氧生态位的适应
Front Cardiovasc Med. 2022 Mar 23;9:814076. doi: 10.3389/fcvm.2022.814076. eCollection 2022.
3
Hepatoprotective effects of flavonoids from common buckwheat hulls in type 2 diabetic rats and HepG2 cells.苦荞麦壳中黄酮类化合物对2型糖尿病大鼠和HepG2细胞的肝脏保护作用
Food Sci Nutr. 2021 Jul 7;9(9):4793-4802. doi: 10.1002/fsn3.2390. eCollection 2021 Sep.
4
Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway.二肽基肽酶-4（DPP4）抑制剂西他列汀通过作为活性氧清除剂和抑制核因子κB（NFκB）途径来减轻糖尿病小鼠的肝脏炎症。
Cell Death Discov. 2021 Sep 7;7(1):236. doi: 10.1038/s41420-021-00625-7.
5
Fasting Blood Glucose, Cholesterol, and Risk of Primary Liver Cancer: The Kailuan Study.空腹血糖、胆固醇与原发性肝癌风险：开滦研究。
Cancer Res Treat. 2021 Oct;53(4):1113-1122. doi: 10.4143/crt.2020.817. Epub 2021 Jan 19.
6
Management of Diabetes Mellitus in Patients with Chronic Liver Diseases.慢性肝脏疾病患者的糖尿病管理。
J Diabetes Res. 2019 Dec 14;2019:6430486. doi: 10.1155/2019/6430486. eCollection 2019.
本文引用的文献
1
Reversion of disease manifestations after HCV eradication.HCV 清除后疾病表现的逆转。
J Hepatol. 2016 Oct;65(1 Suppl):S95-S108. doi: 10.1016/j.jhep.2016.07.039.
2
Metabolic complications in liver transplant recipients.肝移植受者的代谢并发症
World J Gastroenterol. 2016 Jul 28;22(28):6416-23. doi: 10.3748/wjg.v22.i28.6416.
3
Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.糖尿病会增加肝细胞癌的风险，但丙型肝炎肝硬化患者除外。
Am J Gastroenterol. 2016 Nov;111(11):1573-1580. doi: 10.1038/ajg.2016.330. Epub 2016 Aug 16.
4
Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection.与慢性丙型肝炎病毒感染相关的代谢表现及并发症
Gastroenterol Hepatol (N Y). 2016 May;12(5):293-9.
5
High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients.2型糖尿病患者中未诊断出的肝硬化和晚期肝纤维化患病率高。
Ann Hepatol. 2016 Sep-Oct;15(5):721-8. doi: 10.5604/16652681.1212434.
6
Diabetes mellitus and metformin in hepatocellular carcinoma.糖尿病与二甲双胍在肝细胞癌中的作用
World J Gastroenterol. 2016 Jul 21;22(27):6100-13. doi: 10.3748/wjg.v22.i27.6100.
7
Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes.2型糖尿病患者肝细胞癌风险增加的预测因素
PLoS One. 2016 Jun 30;11(6):e0158066. doi: 10.1371/journal.pone.0158066. eCollection 2016.
8
Prevalence, predictive factors, and survival outcome of new-onset diabetes after liver transplantation: A population-based cohort study.肝移植术后新发糖尿病的患病率、预测因素及生存结局：一项基于人群的队列研究。
Medicine (Baltimore). 2016 Jun;95(25):e3829. doi: 10.1097/MD.0000000000003829.
9
Liver Stiffness Evaluation by Transient Elastography in Type 2 Diabetes Mellitus Patients with Ultrasound-proven Steatosis.超声证实脂肪变的 2 型糖尿病患者通过瞬时弹性成像技术进行肝硬度评估。
J Gastrointestin Liver Dis. 2016 Jun;25(2):167-74. doi: 10.15403/jgld.2014.1121.252.lsf.
10
Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.无既往乙型肝炎病毒感染的非B非C型肝细胞癌的临床病理特征
Hepatol Res. 2017 Apr;47(5):405-418. doi: 10.1111/hepr.12762. Epub 2016 Jul 24.
Zotero 插件